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Abstract. In-depth site-specific investigations of protein glycosylation are the basis
for understanding the biological function of glycoproteins. Mass spectrometry-based
N- and O-glycopeptide analyses enable determination of the glycosylation site, site
occupancy, as well as glycan varieties present on a particular site. However, the
depth of information is highly dependent on the applied analytical tools, including
glycopeptide fragmentation regimes and automated data analysis. Here, we used a
small set of synthetic disialylated, biantennary N-glycopeptides to systematically tune
Q-TOF instrument parameters towards optimal energy stepping collision induced
dissociation (CID) of glycopeptides. A linear dependency of m/z-ratio and optimal
fragmentation energywas found, showing that with increasingm/z-ratio, more energy
is required for glycopeptide fragmentation. Based on these optimized fragmentation parameters, a method
combining lower- and higher-energy CID was developed, allowing the online acquisition of glycan and peptide-
specific fragments within a single tandem MS experiment. We validated this method analyzing a set of human
immunoglobulins (IgA1+2, sIgA, IgG1+2, IgE, IgD, IgM) as well as bovine fetuin. These optimized fragmentation
parameters also enabled software-assisted glycopeptide assignment of both N- and O-glycopeptides including
information about themost abundant glycan compositions, peptide sequence and putative structures. Twenty-six
out of 30 N-glycopeptides and four out of five O-glycopeptides carrying >110 different glycoforms could be
identified by this optimized LC-ESI tandem MS method with minimal user input. The Q-TOF based glycopeptide
analysis platform presented here opens the way to a range of different applications in glycoproteomics research
as well as biopharmaceutical development and quality control.
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Introduction
Protein glycosylation is one of the most common post-translational modifications [1]. The vast majority of
membrane and secreted proteins are known or predicted to be
N- and O-glycosylated [1–4]. Glycoproteins represent key
molecules in many important biological processes such as cell
adhesion, endocytosis, receptor activation, signal transduction,
molecular trafficking, and clearance, as well as in diseases,
including cancer [5, 6]. In-depth approaches to determine
site-specific protein glycosylation have become indispensable
tools for functional analyses of these complex biomolecules
[7–9]. Specific glycans present on individual sites of a protein
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have been shown to be crucial for influencing the physico-
chemical and functional properties of their respective protein
carriers. The presence or absence of a single core fucose
attached to biantennary complex-type structures of the crystal-
lizable fragment (Fc) domain of immunoglobulin G (IgG)
influences the interaction of the antibody with its Fcγ-receptor,
leading to a modulation of the antibody-dependent cellular
cytotoxicity [10]. In IgE, the site-specific presence of an
oligomannose-type N-glycan has been shown to be necessary
for initiating anaphylaxis [11]. These examples illustrate that
knowledge about site-specific glycosylation is an important
prerequisite for studying the functional impact of protein
glycosylation.
Glycoproteomic approaches, with focus on the analysis of
N- and O-glycopeptides, can give detailed information on the
type of structures present at a given site of a specific protein.
The high sensitivity and selectivity of modern mass spectrom-
eters in combination with different ionization methods, frag-
mentation techniques, and mass analyzers have made mass
spectrometry the method of choice in glycoproteomics.
However, analysis of glycopeptides can still be hindered by
their low abundance in the entire peptide pool after proteolytic
digestion because of their microheterogeneity (glycan variety
attached to one glycosylation site) and macroheterogeneity
(site occupancy). Furthermore, they have a general tendency
to be less well ionized compared with non-glycosylated pep-
tides [12], which can be compensated but not avoided by
dedicated enrichment steps such as lectin affinity chromatog-
raphy or hydrophilic interaction liquid chromatography
(HILIC) [13, 14].
Glycopeptide fragmentation via tandem mass spectrometry
can be achieved under standard collision induced dissociation
(CID) conditions, preferentially yielding glycan fragments by
cleaving the glycosidic bonds between carbohydrate units (B-
and Y-ions), but rarely providing sufficient peptide b- and y-
type ions (cleavage of peptide bond) for unambiguous peptide
identification [15]. Higher-energy CID (HCD), in contrast,
mainly results in b/y-type peptide ions as well as glycan
oxonium ions and fewer Y-type ions from fragmentation of
the glycosidic linkage [16]. Alternatively, electron transfer
dissociation (ETD) and electron capture dissociation
(ECD) keep the glycan portion on the modified amino
acid mainly intact and the observed c- and z-ions pro-
duced by the N–Cα bond cleavage can provide amino
acid sequence information complementary to CID frag-
mentation [13, 14]. However, because of their size, the
majority of glycopeptides are usually detected in the m/z
range >900 Da, thus impeding with ETD experiments.
Though Alley et al. reported that ETD was able to
provide useful spectra for glycopeptide precursors below
m/z 1400 [17], our experience shows that best results are
obtained for highly charged precursors (≥+3) in an m/z
range <850 Da (personal observation).
Simultaneous acquisition of MS spectra at lower and higher
collision energies (collision energy stepping CID) represents an
attractive approach for selectively yielding fragment ions
covering both the glycan and the peptide moieties of glycopep-
tides [18–21]. Nevertheless, in case higher dissociation ener-
gies are to be applied, adjusting the optimal fragmentation
conditions is a prerequisite to ensure optimal fragmentation
results [19], especially for the peptide part. In that context,
synthetic and highly defined glycopeptide standards represent
a unique and ideal tool to systematically determine the optimal
conditions for glycopeptide fragmentation.
Successful large scale and software-assisted data analysis of
glycopeptide product-ion spectra is not only instrument-
dependent but also requires dedicated software tools. Despite
the fact that great achievements have been made in this field
within the last years, recent reviews on available software
packages also pointed out some shortcomings due to the lack
of desirable functions for comprehensive and automated gly-
copeptide analysis [22, 23]. Important features, such as eluci-
dation of N- and O-glycans, matching of peptides to known
protein sequences, scoring (ranking) of potential glycan and
peptide moieties, parallel detection of non-glycosylated pep-
tides, usage of product-ion data, or the option for batch inputs,
have hitherto not been realized within a single software tool
[22, 23].
Here we used synthetic and thus well-defined N-glycopep-
tides for the systematic optimization of CID energy parameters
on quadrupole-time of flight (Q-TOF) instruments to obtain
maximum information on both the glycan and peptide moiety
within a single tandem MS experiment. Synthetic glycopep-
tides carrying biantennary, disialylated N-glycans were used to
elucidate optimal collision energies for both the glycan and the
peptide fraction. The optimized parameters were subsequently
validated in a LC-ESI tandem MS online setup using tryptic
peptides derived from the entire panel of human immunoglob-
ulins (Igs) and bovine fetuin. Glycopeptide fragment data
obtained from these optimized collision energy stepping CID
conditions enabled software-assisted N- and O-glycopeptide
data analysis in a semi-automated manner, including glycopep-




If not otherwise stated, all materials were purchased in high
quality from Sigma-Aldrich (St. Louis, MO, USA). Trypsin
(sequencing grade) was obtained from Roche Diagnostic
GmbH (Mannheim, Germany). Water was used after purifica-
tion with a Milli Q-8 direct system (Merck KGaA, Darmstadt,
Germany). IgA (plasma), sIgA (human colostrum), IgD (plas-
ma), IgE (myeloma plasma, lambda), IgG1 (myeloma plasma,
kappa), IgG2 (myeloma plasma, kappa), and IgM (plasma)
were obtained from Athens Research & Technology
(Athens, GA, USA). The amino acid numbering applied for
all proteins analyzed in this study is based on the respective
UniProtKB entries.
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Glycopeptide Design and Purification
A tryptic N-glycosylated peptide sequence present in human
protein C (entry P04070, 284EVFVHPNYSK293) [24] was se-
lected to design a small panel of synthetic N-glycopeptide
standards. Besides the naturally occurring peptide sequence
(termed GP-M), variations of the sequence were produced with
the glycosylated amino acid either moved towards the N-
terminus (GP-N) or the C-terminus (GP-C) of the peptide
sequence. All glycopeptides were synthesized carrying a
disialylated, biantennary N-glycan (Table 1). Glycopeptide
synthesis and purification were performed as described previ-
ously [12].
Systematic Optimization of Collision Energy
Parameters for Glycopeptide Fragmentation
Synthetic glycopeptides were dissolved in 50% acetonitrile
(ACN) containing 0.1% formic acid (FA) and used for direct
infusion experiments (500 fmol/μL) on a Q-TOF impact II
(Compass 1.9, otofControl 4.0) interfaced with an electrospray
ionization (ESI) Apollo source (both Bruker, Bremen,
Germany). Data was acquired using a modified version of the
standard Instant Expertise method in which the product-ion
spectra rate was 4–16 Hz (depending upon precursor intensity)
and the number of precursors selected for fragmentation is
adjusted automatically to retain a MS-tandem MS duty cycle
of 3 s. For this experiment, precursors were manually selected
but the tandem MS spectra rate was automatically determined
as above. MS spectra were acquired at 2 Hz and precursors
were isolated with a width of 3–5 Da depending onm/z values.
Collision energies were increased from 10 to 140 eV in steps of
10 eV; for each collision energy data was acquired for 2 min in
the range 150–2300 m/z.
Further Optimization of Collision Energies
on the Basis of LC-Separated Tryptic Glycopeptides
Correlations between collision energies and m/z values of
glycopeptides were investigated by mixing synthetic peptides
with glycopeptides derived from colon biopsies of patients with
ulcerative colitis. Samples were taken with informed patient
consent, ethical approval no. 39/2001. Detailed information on
sample preparation can be found in the Supplementary
Information.
Tryptic and synthetic peptide (500 fmol) mixtures, dis-
solved in 0.1% FA, were trapped on a C18 pre-column
(Acclaim PepMap RSLC Nano-Trap column; 3 μm, 100 Å,
75 μm × 20 mm, Thermo Fisher Scientific, Waltham, MA,
USA) and separated on a C18 analytical column (Acclaim
PepMap RSLC column; 2 μm, 100 Å, 75 μm × 150 mm,
Thermo Fisher Scientific) using a linear gradient from 2%
buffer B (100% ACN, 0.1% FA) to 50% in 30 min, with buffer
A containing 0.1% FA. The flow rate was set to 300 nL/min
and oven temperature to 40 °C. The impact II was interfaced
with the CaptiveSpray nanoBooster source (Bruker). MS and
tandemMS data were acquired at 1 Hz from 50–3000m/zwith
precursor selection in the range of 650–2000 m/z. In each MS
cycle, one MS spectrum was followed by product-ion spectra
of the three most intense precursors using an isolated width of
5–7.5 Da. The collision energy was set to a different value in
each of 13 separate acquisitions, increasing from 10 to 130 eV
in steps of 10 eV.
Application of Optimized Fragmentation
Parameters to Standard Glycoproteins
The optimized parameter settings determined for the synthetic
glycopeptides were applied in the analysis of tryptic (glyco-)
peptides obtained from bovine fetuin and various human Igs.
Purified IgA, sIgA, IgD, IgE, IgG1, IgG2, and IgM were
separated by sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE) (Supplementary Figure 3) and the
respective heavy chain bands in-gel-digested with trypsin, as
described previously [25]. Fetuin was digested in solution as
described elsewhere [26].
Setup One Tryptic digests (1:7 dilution, dissolved in 2%
ACN, 1 μL) were analyzed using the experimental setup de-
scribed above with some modifications. The LC gradient was
Table 1. Synthetic N-Glycopeptides Used for Optimizing Q-TOF Fragmentation Conditions
Name Sequence Glycan [M + H]+ [M + 2H]2+ [M + 3H]3+ [M + 4H]4+
GP-N ENYSVFVHPK 3424.3830 1712.6952 1142.1325 856.8512
GP-M EVFVHPNYSK 3424.3830 1712.6952 1142.1325 856.8512
GP-C EVFVHPYSNK 3424.3830 1712.6952 1142.1325 856.8512
N-Acetylglucosamine, Mannose, Galactose, N-Acetylneuraminic acid     
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set from 5% to 50% solvent B in 60 min. Data was acquired
using another modified version of the standard Instant
Expertise method, which had a MS-tandem MS duty cycle of
3.5 s. MS was fixed to 2 Hz and the product-ion spectra rate
was variable in the range 1.5–4 Hz depending upon precursor
intensity. Precursors were automatically selected in the range of
650 to 3000 m/z and fragmented with an isolation width of 8–
10 Da depending on m/z values. Collision energies were in-
creased linearly in a m/z dependent manner from 55 eV at m/z
700 to 124 eV at m/z 1800, for all charge states. These values
were applied to 80% of the TOF summations used for each
spectrum; for the remaining 20% the collision energy was
halved. In this mode of operation, ion counts from each subdi-
vision are summed together.
Setup Two Tryptic digests were also analyzed on an additional
liquid chromatography-electrospray ionization-quadrupole-time
of flight-mass spectrometry (LC-ESI-Q-TOF-MS) system. In
detail, LC-QTOF-tandem MS analysis on a nano reverse phase
(RP) column was performed on a maXis HD Q-TOF mass
spectrometer equipped with a CaptiveSpray nanoBooster source
(both Bruker) coupled to a Ultimate 3000 nano ultra-
performance liquid chromatography system (Thermo
Scientific, Breda, The Netherlands). The mass spectrometer
and the LC were controlled by Hystar 3.2 (Bruker).
One microliter of the tryptic digest (1:7 dilution, dissolved
in water) was loaded onto a C18 μ-pre column (PepMap100;
300 μm × 5 mm, 5 μm, 100 Å, Thermo Scientific) with 10 μL/
min of 99% water/ 1% ACN/ 0.05% TFA for 5 min. (Glyco-)
peptides were separated on a C18 analytical column (Acclaim
PepMap RSLC; 75 μm × 15 cm, 2 μm, 100 Å, Thermo
Scientific, Breda) and elution was performed at a flow
rate of 700 nL/min with buffer A [water containing 0.1%
FA (v/v)] and buffer B [80% acetonitrile/20% water
containing 0.1% FA (v/v)]. A linear gradient of 3%–
40% buffer B in 15 min was applied followed by col-
umn washing and reconditioning.
The CaptiveSpray nanoBooster was operated with
acetonitrile-enriched gas (0.2 bar) and 3 L/min dry gas at
150 °C and a capillary voltage of 1200 V. MS spectra were
acquired within a mass range of m/z 50–2800. As before, basic
stepping mode was applied for the tandemMS collision energy
(100%–50%) each 80% and 20% of the time, respectively, and
collision energies were set as a linear curve in a m/z dependent
manner ranging from 55 eV at m/z 700 to 124 eV at m/z 1800,
for all charge states. In this setup, product-ion spectra were
generated from the three most abundant precursors in a range of
m/z 550–2800 with an isolation width of 8–10 Da depending
on m/z values. MS was performed at a spectra rate of 1 Hz,
tandem MS at 0.5 to 2 Hz dependent upon precursor intensity.
Software Assisted Glycopeptide Data Analysis
Software-assisted glycopeptide data analysis DataAnalysis 4.4
was used for the generation of peak lists in the .XML format,
which were then further analyzed using the bioinformatics
platform ProteinScape 4.0 (Bruker). The classification step,
which filters for glycopeptide spectra and determines the re-
spective masses of the peptide and glycan moieties, was per-
formed as described previously based on the presence of
oxonium ions and monosaccharide distances [27].
The exact parameter settings used for the classification as
well as for the peptide and glycopeptide searches are listed in
Supplementary Figure 4. GlycoQuest, the glycan search engine
integrated in ProteinScape, was used to search potential corre-
sponding glycan compositions within the glycan structure da-
tabase GlycomeDB (www.glycome-db.org), using the glycan
masses determined in the classification step. ProteinScape 4.0
automatically replaced the experimentally determined
precursor mass of respective glycopeptides with the
calculated peptide mass for subsequent mascot analyses. This
enabled the peptide moiety to be identified using an in-house
Mascot Server version 2.3 or 2.4 (Matrix Science Ltd., UK).
The collision energy optimum for peptides is the maximum of
the peptide intensity coverage plotted against the applied col-
lision energies. The peptide intensity coverage itself is a value
that is the sum of the intensities of all fragments explained by
peptide fragmentation divided by the sum of the intensities of
all product-ion spectra signals, and thus provides a good com-
parative value for evaluating both presence and intensity of
peptide specific fragments. The GlycoQuest score, which com-
bines the glycan fragmentation coverage and the glycan inten-
sity coverage, was used for determining the collision energy
optimum for glycan fragmentation.
The collision energy optimum for peptides is the maximum
of the peptide intensity coverage plotted against the applied
collision energies. The peptide intensity coverage itself is a
value that is the sum of the intensities of all fragments ex-
plained by peptide fragmentation divided by the sum of the
intensities of all product-ion spectra signals, and thus provides
a good comparative value for evaluating both presence and
intensity of peptide specific fragments. The GlycoQuest score
was used for determining the collision energy optimum for
glycan fragmentation.
Results and Discussion
Optimization of Glycopeptide Fragmentation Using
Synthetic N-Glycopeptides
A panel of defined N-glycopeptides was synthesized to sys-
tematically elucidate the optimal fragmentation conditions for
glycopeptides in Q-TOF instruments. A maximum on peptide
sequence as well as glycan composition data should be simul-
taneously acquired on the chemically distinctive fractions
while minimizing dwelling and acquisition times within the
instrument. The optimal settings were elucidated using the
peptide intensity coverage score as an indicator for optimal
peptide fragmentation conditions, whereas the GlycoQuest
score indicated when a maximum of information could be
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obtained for the glycan moieties. This was then confirmed by
manual validation of the spectra.
The collision energies applied to fragment the glycopeptides
were increased in 10 eV steps from 10 to 140 eV. These
analyses revealed distinguished fragmentation optima for the
glycan and the peptide moieties (Figure 1). Independent from
the precursor charge, higher energies were required to obtain
optimal dissociation of the peptide moieties. Around 30 eV
provided the highest GlycoQuest score for the quadruply
charged GP-M, indicating this value to be the optimal collision
energy to obtain a maximum of information on the glycan
moiety. For the same glycopeptide, around 65 eV were re-
quired to achieve the highest peptide intensity coverage. The
data showed that the peptide moieties had a somewhat
narrower fragmentation energy optimum compared with the
glycan part (Figure 1a, b). We also confirmed glycopeptide
fragmentation energies to be m/z-dependent, and lower colli-
sion energies were required for compounds with a lower m/z
[19, 28, 29].
Interestingly, although the collision energies required for
fragmentation of the peptide moiety for all three synthetic N-
glycopeptides overlapped with each other, the collision energy
optimum for the peptide moiety of GP-N was lower compared
with the other two. In addition, the intensity coverage deter-
mined for GP-N was generally reduced over the entire collision
energy range of the analyzed charge state (Figure 1c). The
specific GP-N amino acid sequence as well as the position of
the N-glycan present are possible explanations for the observed
phenomenon, indicating that either the peptide sequence, the
N-terminal proximity, or both influence the specific fragmen-
tation behavior of this glycopeptide. In contrast, the glycan-
specific collision energy optima were comparable for all three
precursors, indicating that the specific amino acid sequence
appears to have no or just negligible influence on the fragmen-
tation of the N-glycans (Figure 1d). Exemplary fragment spec-
tra for the doubly charged GP-M recorded under different
collision energies (70, 100, 120 eV) are included in the
Supplementary Figure 1.
Further Optimization of Collision Energies Using
LC-Separated Tryptic Glycopeptides
The collision energies and instrument settings were further
optimized for a larger set of glycopeptides during a represen-
tative LC-ESI tandem MS experiment. The synthetic glyco-
peptide GP-M was mixed into a HILIC-enriched (glyco-)pep-
tide fraction obtained after tryptic in-gel protein digestion of a
randomly chosen SDS-PAGE band from human colon biopsy
samples (Supplementary Figure 2). Overall, 16 different gly-
copeptide species ranging over four different charge states
derived from four different proteins were successfully identi-
fied in addition to the synthetic glycopeptide GP-M
(Supplementary Table 1). A range of different collision ener-
gies from 10 to 130 eV (10 eV steps) was applied to determine
Figure 1. Collision energy optima for synthetic N-glycopeptides. For the peptide part, the intensity coveragewas plotted versus the
applied collision energy, and for the glycan part, the GlycoQuest score was used. From these plots, the respective optima were
determined (refer to text for further details). For GP-M (left), the optimal collision energies were determined for charge states 2+, 3+,
4+, and 5+ (a) peptide part; (b) glycan part). Error bars represent the standard deviation determined from an average of approxi-
mately 180 individual product-ion spectra. Right: determination of the optimal collision energies for all three synthetic glycopeptides
[charge 4+ (c) peptide part; (d) glycan part)]
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the optimal information output based on the GlycoQuest Score
and peptide intensity coverage. The best balance was obtained
when 80% of the fragmentation time was allocated to the
higher energy CID conditions for acquiring peptide specific
fragments. Lower energy conditions were applied for the re-
maining 20% fragmentation time to acquire glycan-specific
fragments induced by glycosidic bond cleavages. Depending
on the individual experimental requirements, more time can be
allocated to the lower energy fragmentation conditions if more
glyco-related fragments are desired and vice versa.
A linear dependency of the collision energy optimum and
the m/z ratio was observed when the collision energies were
stepwise incremented. This further confirmed the general trend
that precursors with higher m/z ratios require higher collision
energies for optimal fragmentation (Figure 2). Depending on
the particular peptide composition and the distribution of cer-
tain amino acids within a peptide sequence, the availability of
readily mobile protons may vary, resulting in slightly deviated
optimized collision energies. This is best exemplified by our
data obtained for glycopeptide GP-N (Figure 1c), but has also
been described previously [19, 30]. Nonetheless, the optimized
collision energies initially determined on the synthetic N-
glycopeptides could be further refined using glycopeptides
with various peptide backbones and glycan structures. Based
on these results, a collision energymethodwas employed using
55 eV at m/z 700 to 124 eV at m/z 1800 as high-energy values
for 80% of the fragmentation time before the energy values
were halved for the remaining 20%.
Method Application: Analysis of Tryptic (Glyco-)
Peptides Derived from Various Human
Immunoglobulins and Bovine Fetuin
With the optimized collision energy method at hand, we set out
to benchmark the method using tryptic (glyco-)peptides obtain-
ed from various human Igs (IgA1+2, sIgA [secretory compo-
nent, joining chain, IgA1+2], IgD, IgE, IgG1+2, and IgM) as
well as bovine fetuin. These glycoproteins contain both N- and
O-glycopeptides and are well described (references in Table 2),
which makes them prime model samples for a systematic
evaluation of the optimized collision energy settings as well
as the automated glycopeptide data analysis software embed-
ded in ProteinScape 4.0.
The 10 glycoproteins investigated here have been previous-
ly reported to contain 33 N- and 18 O-glycosylation sites
(Table 2). In silico digestion with trypsin (not taking missed
cleavages into account) predicted 30 N-glycopeptides and five
O-glycopeptides resulting from these glycoproteins. The indi-
vidual tryptic digests were subjected to nanoRP-LC-ESI-Q-
TOF tandem MS using the optimized method and without
any further glycopeptide enrichment. Analysis of the obtained
data with ProteinScape 4.0 revealed peptide sequences and
glycan compositions of 21 tryptic N- and two O-
glycopeptides (Table 2). The obtained spectra contained both
features, B- and Y-ions resulting from the glycan fragmentation
of lower-energy CID as well as b- and y-ions of the peptide
portion attributable to the enhanced energy (Figure 3).
ProteinScape also correctly classified seven additional spectra
as glycopeptides, which could, however, not be positively
associated with any protein by the software algorithm.
Manual inspection of the spectra confirmed the initial glyco-
peptide classification, but also revealed the reason why they
could not be automatically assigned. Most of these glyco-
classified but unassigned spectra derived from glycopeptides
with multiple sites of glycosylation. This holds true for the
tryptic IgA1-peptide His89-Arg126, which can contain up to
five O-glycosylation sites (Ser105, Ser111, Ser113, Ser119,
Ser121). Additionally, this glycopeptide also shows a promi-
nent fragmentation of the peptide backbone (b11, y27 + glycan)
with retention of (parts of the) glycan moieties (Figure 4,
Table 2), which prohibited the algorithm from determining a
correct peptide mass of this highly complex glycopeptide.
IgD is the second glycoprotein in this panel for which up to
seven sites of O-glycosylation have been reported earlier
(Ser109, Ser110, Thr113, Thr126, Thr127, Thr131, and
Thr132) [31, 32]. Similar to the IgA1 hinge-region glycopep-
tide (Figure 4), the detected tryptic glycopeptide Ala106-
Arg137 (containing two missed cleavages) did not exhibit a
fragmentation pattern, which resulted in a Bpeptide-only^ or
Bpeptide + HexNAc^ fragment; instead a Bpeptide +
Hex2HexNAc3NeuAc^ was the smallest Y-type ion detected
(Supplementary Figure 5). Thus, it was impossible for the
ProteinScape algorithm to determine the right peptide mass
value needed for automated glycopeptide assignment of this
multiply glycosylated peptide. It is likely that an automated
Figure 2. Correlation between precursor m/z and optimal col-
lision energies. Synthetic glycopeptides (diamonds) were
spiked into a mixture of glycopeptides (circles) enriched from
a tryptic digest derived from a complex sample and analyzed
via C18-RP-LC-ESI-Q-TOF tandem MS. For the [M + 5H]5+
species and partially for the [M + 4H]4+ species of the synthetic
glycopeptides, values were obtained additionally by direct infu-
sion. The optimal collision energies for peptide backbone and
glycan moiety were determined based on GlycoQuest Score
and peptide intensity coverage. [M + 5H]5+ species are indicat-
ed in orange, [M + 4H]4+ in blue, [M + 3H]3+ in green, and [M +
2H]2+ in black
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assignment of such complex product-ion spectra by currently
available software tools will deliver similar results, though this
was not further evaluated and tested in the course of this study.
The remaining five glycosylation sites that were classified as
glycopeptides but not identified by the software showed low-
intensity peptide b- and y-ions and thus could not be assigned
automatically.
The intrinsic nature of the residual, as yet undetected, gly-
copeptides from this sample set was most likely responsible for
why they evaded identification or were not detected at all. The
predicted tryptic glycopeptides from IgE (Asn17-Lys80 [N-
glycan at N21 and N49]) and Ile116-Lys183 (N-glycan at
N146), from bovine fetuin (Val246-Arg306 [O-glycans at
Ser271, Thr280, Ser282, and Ser296]) and from IgA2 (Val8-
Arg51 [N-glycan at N47]) are all large glycopeptides with a
length of more than 40 amino acids. Under the applied analysis
conditions these compounds are possibly too hydrophobic and
therefore likely to be retained irreversibly on the C18 stationary
phase.
In addition, multiply glycosylated peptides such as IgE
Asn17-Lys80, IgM Thr269-Arg300, secretory component
Ala82-Arg107, and fetuin Val246-Arg306 will also carry
various charges and exhibit a higher glyco-heterogeneity com-
pared with glycopeptides with a single site of glycosylation.
These factors will additionally contribute to expected overall
lower signal intensities, which also makes it less likely that
these signals will be selected for tandemMS experiments under
data-dependent selection criteria. As demonstrated earlier, the
use of alternative and/or multiple proteases resulting in smaller,
less heterogeneous sets of distinguished glycopeptides repre-
sents one opportunity to cover these sites [25, 33–35].
In the course of this study, no glycopeptides or peptides
covering N327 from IgA2 could be identified, which might be
explained by incomplete site occupation or lower ionization
efficiency of the glycopeptide. Potential alterations on the C-
terminus of the IgA2 used in this study could also result in
different peptide backbones that evaded detection/identifica-
tion. In contradiction to other studies claiming N92 in IgA2 to
be quantitatively N-glycosylated despite the presence of a
P r o l i n e w i t h i n t h e N - g l y c o s y l a t i o n s e q u o n
(89HYTNPSQDVTVPCPVPPPPPCCHPR113) [36], we were
not able to detect the respective site being N-glycosylated at
all. Nevertheless, the non-glycosylated tryptic peptide could
clearly be detected and identified (Supplementary Figure 6),
Figure 3. Representative spectra of automatically assigned N- and O-glycopeptides from IgD using the optimized Q-TOF collision
energy stepping dissociation method. (a) tryptic N-glycopeptide TLLNASR (N367, [M + 3H]3+ at m/z 910.386) carrying a
Hex5HexNAc5NeuAc N-glycan. The specific glycopeptide spectrum provided sufficient information to assign it as a monosialylated
diantennaryN-glycan with a bisecting GlcNAc. (b) TrypticO-glycopeptide AQASSVPTAQPQAEGSLAK (Ser109, Ser110, Thr113) [M
+ 3H] 3+ at m/z 930.089 with a disialylated core 1 type glycan attached
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which is also in line with previous in-depth glycoproteomic
data on secretory IgA [37]. Even manual inspection for traces
of glycosylation on this site did not, at least in the sample set
analyzed, result in any detectable form of glycosylation on
N92.
The optimized collision energy stepping CID conditions
reported here were found to deliver solid glycan composition
as well as peptide sequence information for precursor ions
distributed over a wide m/z range. Compared with alternative
fragmentation techniques such as ETD, we found collision
energy stepping CID to be more robust in delivering useful
data within a data-dependent LC-ESI tandem MS experiment,
in particular if precursors with high m/z values were selected.
Nevertheless, collision energy stepping CID also efficiently
fragmented the linkage between the oligosaccharide and the
peptide, making it practically impossible to determine sites of
glycosylation by this approach. Though this is of less signifi-
cance for N-glycosylated peptides because of the well
Figure 4. Product-ion spectra of a manually identified IgA1 O-glycopeptide using the optimized Q-TOF collision energy stepping
dissociation method. The glycopeptide [M + 5H]5+ 1146.0924 with 89His-Arg126 has several occupied O-glycosylation sites with a
total composition of Hex3HexNAc4NeuAc. The glycopeptide could not be identified automatically because the peptide backbone
also fragmented into b11 and y27 + glycan fragments. Diagnostic b-ion fragments of the y27 initial fragment are highlighted in red.
Note the specific, proline-rich nature of the peptide sequence, resulting in fragments with larger sequence gaps
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preserved glycosylation sequon, it poses certain drawbacks for
site determination of post-translational modifications where the
specific sites cannot be reliably predicted from the protein
sequence (e.g., O-glycans or phosphorylation). However, colli-
sion energy stepping CID still provides a valuable first data set
on peptide sequence and glycan composition even for multiply
O-glycosylated peptides (Figure 4 and Supplementary Figure 5).
Based on such results, alternative and targeted approaches can
subsequently be applied where both sample preparation and
acquisition parameters can be optimized to gain site attachment
information using ETD [38, 39].
The glycoforms reported in this study on the respective sites
of glycosylation represent only glycoforms that were selected
and confirmed by product-ion spectra (Table 2); thus, the data
does not represent the full variety of glycosylation present on
specific sites. Several additional glycoformswere obvious from
the MS1 data but are not reported since identification on MS-
level and overall site-specific glycosylation heterogeneity were
not the scope of this study. It should be noted that all identified
glycopeptides were in line with previously published literature
(see references in Table 2) and with currently accepted, repeat-
edly verified general knowledge on protein N-glycosylation.
Conclusions
Overall, the optimization of CID energy parameters for Q-TOF
instruments using synthetic N-glycopeptides yielded improved
fragmentation for both the glycan and the peptide moiety. To
obtain optimal fragmentation data, peptide moieties required
generally higher energies. Twice the energy (compared with the
glycan portion) was applied for 80% of the fragmentation time to
obtain sufficient peptide bond cleavages. Under the conditions
applied in this study, the most informative glycopeptide spectra
were obtained when collision energies of 55 eV at 700 m/z to
124 eV at 1800 m/z were applied in a m/z dependent manner.
The applied fragmentation conditions are well suited to a
broad range of glycopeptides. This is exemplified by data
showing that the positioning of the glycan moiety on the
peptide and/or slight sequence differences only lead to a small
change in optimum collision energy for the peptide moiety.
Furthermore, the peptide portion did not influence the optimal
fragmentation conditions for the glycan part of the glycopep-
tides, at least for the ones analyzed in this study.
Glycopeptide fragmentation aspects on Q-TOF instruments
has been the subject of investigation previously [19–21]. One
of the earliest reports by Jebanathirajah et al. described glycan
and peptide specific fragmentation aspects using synthetic N-
and O-glycopeptides carrying a disaccharide [20]. The non-
tryptic nature of these compounds, however, is likely to affect
the fragmentation compared with tryptic glycopeptides.
Recently, Kolli and Dodds reported a systematic in-depth
investigation of enriched, tryptic glycopeptides from bovine
ribonuclease B and Erythrina cristagalli lectin [19]. In this
excellent study that evaluated glycan as well as peptide frag-
mentation aspects, both investigated glycopeptides carried
neutral N-glycans with a maximum of seven monosaccharide
residues. Other reports mainly focused on the fragmentation
characteristics of the glycan part only, without further dissoci-
ation of the peptide backbone [21]. The data presented here is,
to the best of our knowledge, the first to systematically opti-
mize fragmentation conditions of tryptic glycopeptides carry-
ing complex biantennary, disialylated N-glycans and validate
these optimized fragmentation parameters by performing a
glycoproteomic investigation of the entire panel of human
immunoglobulins (IgA, sIgA, IgD, IgE, IgG1, IgG2, and
IgM) and bovine fetuin. Using the optimized MS parameters,
most of the expected glycopeptides reported in literature could
be identified. Peptide sequence as well as glycan composition
data were obtained on a representative range of glycopeptides
carrying N- as well as O-glycans.
Our results also highlight how bioinformatic tools strongly
benefit from data acquired under optimized acquisition param-
eters. Software-assisted data analysis (ProteinScape 4.0) not
only successfully identified N- and O-glycopeptides but also
elucidated several glycoforms and made putative structure
suggestions. The optimized methodology for glycopeptide
analyses presented here using Q-TOF instruments and the
associated computational tools will prove to be particularly
useful in the fields of glycoproteomics research as well as
biopharmaceutical development and quality control applica-
tions. The major challenges for glycopeptide characterization
in complex biological sample matrices remain their lower
ionization efficiency [12] and efficient and specific enrichment.
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